|
US4960765A
(en)
*
|
1980-03-20 |
1990-10-02 |
Farmaceutisk Laboratorium Ferring A/S |
Pharmaceutical composition and method for the treatment of colitis ulcerosa and Crohn's disease by oral administration
|
|
WO1981002671A1
(en)
*
|
1980-03-20 |
1981-10-01 |
Ferring Farma Lab |
Pharmaceutical composition and method for the treatment of colitis ulcerosa and crohn's disease by oral administration
|
|
SE457505B
(sv)
*
|
1984-01-10 |
1989-01-09 |
Lejus Medical Ab |
Laminatbelagd oral farmaceutisk komposition och foerfarande foer dess framstaellning
|
|
IL77186A0
(en)
*
|
1985-11-29 |
1986-04-29 |
Touitou Elka |
Pharmaceutical insulin composition
|
|
EP0265061B1
(en)
*
|
1986-09-18 |
1992-01-08 |
London School of Pharmacy Innovations Ltd |
Pharmaceutical formulation
|
|
GB8707421D0
(en)
*
|
1987-03-27 |
1987-04-29 |
Wellcome Found |
Pharmaceutical formulations
|
|
JPH01299226A
(ja)
*
|
1988-05-27 |
1989-12-04 |
Seikagaku Kogyo Co Ltd |
サラゾスルファピリジン腸溶顆粒
|
|
PT93637A
(pt)
*
|
1989-04-20 |
1990-11-20 |
Procter & Gamble |
Metodo para o tratamento de desordens funcionais intestinais/colonicas, especialmente o sindrome de irritacao intestinal
|
|
US5032405A
(en)
*
|
1989-09-27 |
1991-07-16 |
Warner-Lambert Company |
Oral pharmaceutical composition for acid sensitive proteinaceous agents
|
|
SE8903914D0
(sv)
|
1989-11-22 |
1989-11-22 |
Draco Ab |
Oral composition for the treatment of inflammatory bowel diseases
|
|
US5643602A
(en)
*
|
1989-11-22 |
1997-07-01 |
Astra Aktiebolag |
Oral composition for the treatment of inflammatory bowel disease
|
|
EP0544671A4
(en)
*
|
1990-04-18 |
1993-09-15 |
The University Of Utah |
Colonic-targeted oral drug-dosage forms based on crosslinked hydrogels containing azobonds and exhibiting ph-dependent swelling
|
|
NL9002336A
(nl)
*
|
1990-10-24 |
1992-05-18 |
Leuven K U Res & Dev |
Bekledings- of matrixmateriaal voor geneesmiddelen.
|
|
US5316772A
(en)
*
|
1990-12-19 |
1994-05-31 |
Solvay & Cie, S.A. (Societe Anonyme) |
Bilayered oral pharmaceutical composition with pH dependent release
|
|
GEP19971086B
(en)
*
|
1991-02-22 |
1997-12-02 |
Tillotts Pharma Ag |
Peroral Pharmaceutically Dispensed Form for Selective Introducing of the Medicine into the Intestine
|
|
AU1587392A
(en)
*
|
1991-03-15 |
1992-10-21 |
Norwich Eaton Pharmaceuticals, Inc. |
The use of 5-aminosalicylic acid in the treatment of irritable bowel syndrome - diarrheal phase or type (ibs-d)
|
|
US5654004A
(en)
*
|
1992-11-06 |
1997-08-05 |
Hisamitsu Pharmaceutical Co., Inc. |
Oral pharmaceutical preparation releasable in the lower digestive tract
|
|
US5843479A
(en)
*
|
1993-02-26 |
1998-12-01 |
The Procter & Gamble Company |
Bisacodyl dosage form with multiple enteric polymer coatings for colonic delivery
|
|
US5914132A
(en)
*
|
1993-02-26 |
1999-06-22 |
The Procter & Gamble Company |
Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery
|
|
US5651983A
(en)
*
|
1993-02-26 |
1997-07-29 |
The Procter & Gamble Company |
Bisacodyl dosage form for colonic delivery
|
|
DE69425453T2
(de)
*
|
1993-04-23 |
2001-04-12 |
Novartis Ag, Basel |
Wirkstoffabgabevorrichtung mit gesteuerter Freigabe
|
|
DK66493D0
(da)
*
|
1993-06-08 |
1993-06-08 |
Ferring A S |
Praeparater, isaer til brug ved behandling af inflammatoriske tarmsygdomme eller til at opnaa forbedret saarheling
|
|
US6204243B1
(en)
|
1993-09-01 |
2001-03-20 |
Novatis Ag |
Pharmaceutical preparations for the targeted treatment of crohn's disease and ulcerative colitis
|
|
US6210714B1
(en)
|
1993-11-23 |
2001-04-03 |
Euro-Celtique S.A. |
Immediate release tablet cores of acetaminophen having sustained-release coating
|
|
US5500227A
(en)
*
|
1993-11-23 |
1996-03-19 |
Euro-Celtique, S.A. |
Immediate release tablet cores of insoluble drugs having sustained-release coating
|
|
SE9401738D0
(sv)
*
|
1994-05-19 |
1994-05-19 |
Ewos Ab |
Bioactive feed
|
|
GB9412394D0
(en)
*
|
1994-06-21 |
1994-08-10 |
Danbiosyst Uk |
Colonic drug delivery composition
|
|
GB2303550B
(en)
*
|
1994-06-21 |
1998-07-08 |
Danbiosyst Uk |
Colonic drug delivery system
|
|
US5637319A
(en)
*
|
1995-03-01 |
1997-06-10 |
Takada; Kanji |
Controlled-release preparations
|
|
US6166024A
(en)
|
1995-03-30 |
2000-12-26 |
Mayo Foundation For Medical Education And Research |
Use of topical azathioprine and thioguanine to treat colorectal adenomas
|
|
US20040018236A1
(en)
*
|
1995-05-08 |
2004-01-29 |
Robert Gurny |
Nanoparticles for oral administration of pharmaceutical agents of low solubility
|
|
US5686106A
(en)
*
|
1995-05-17 |
1997-11-11 |
The Procter & Gamble Company |
Pharmaceutical dosage form for colonic delivery
|
|
US6156340A
(en)
*
|
1996-03-29 |
2000-12-05 |
Duquesne University Of The Holy Ghost |
Orally administrable time release drug containing products
|
|
AU2521797A
(en)
*
|
1996-04-12 |
1997-11-07 |
Japan Atomic Energy Research Institute |
Ph-sensitive polymers
|
|
GB9620709D0
(en)
*
|
1996-10-04 |
1996-11-20 |
Danbiosyst Uk |
Colonic delivery of weak acid drugs
|
|
DE19732903A1
(de)
|
1997-07-30 |
1999-02-04 |
Falk Pharma Gmbh |
Pellet-Formulierung zur Behandlung des Intestinaltraktes
|
|
AU4800999A
(en)
|
1998-07-28 |
2000-02-21 |
Tanabe Seiyaku Co., Ltd. |
Preparation capable of releasing drug at target site in intestine
|
|
WO2000016784A1
(fr)
*
|
1998-09-21 |
2000-03-30 |
Amato Pharmaceutical Products, Ltd. |
Systeme d'administration orale de medicament permettant d'ameliorer la biodisponibilite de la glycyrrhetine activee
|
|
US20010055613A1
(en)
|
1998-10-21 |
2001-12-27 |
Beth A. Burnside |
Oral pulsed dose drug delivery system
|
|
IT1303753B1
(it)
*
|
1998-11-13 |
2001-02-23 |
Ct Lab Farm Srl |
Composizioni farmaceutiche somministrabili per via orale contenentiun rivestimento gastroresistente a base di polimeri acrilici.
|
|
MXPA01007463A
(es)
|
1999-01-29 |
2002-06-04 |
Losan Pharma Gmbh |
Composiciones farmaceuticas.
|
|
JP2000247911A
(ja)
|
1999-02-26 |
2000-09-12 |
Hisamitsu Pharmaceut Co Inc |
大腸用吸収促進剤
|
|
WO2000076478A1
(en)
|
1999-06-14 |
2000-12-21 |
Cosmo S.P.A. |
Controlled release and taste masking oral pharmaceutical compositions
|
|
US8895064B2
(en)
|
1999-06-14 |
2014-11-25 |
Cosmo Technologies Limited |
Controlled release and taste masking oral pharmaceutical composition
|
|
IL130602A0
(en)
|
1999-06-22 |
2000-06-01 |
Dexcel Ltd |
Stable benzimidazole formulation
|
|
WO2001002014A1
(fr)
|
1999-07-02 |
2001-01-11 |
Hisamitsu Pharmaceutical Co., Inc. |
Compositions medicamenteuses destinees au traitement du cancer colorectal
|
|
US20030114349A1
(en)
*
|
2000-04-27 |
2003-06-19 |
The Procter & Gamble Company |
Coating composition for solid bodies
|
|
AU6701101A
(en)
|
2000-06-21 |
2002-01-02 |
Cubist Pharm Inc |
Compositions and methods to improve the oral absorption of antimicrobial agents
|
|
ES2254470T3
(es)
|
2000-08-29 |
2006-06-16 |
Nobex Corporation |
Compuestos inmunorreguladores, derivados de los mismos y su uso.
|
|
CA2359812C
(en)
*
|
2000-11-20 |
2004-02-10 |
The Procter & Gamble Company |
Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures
|
|
US20070059368A1
(en)
*
|
2005-05-31 |
2007-03-15 |
Cherukuri S R |
Modified release formulations of anti-irritability drugs
|
|
US8048924B2
(en)
|
2001-08-29 |
2011-11-01 |
Biocon Limited |
Methods and compositions employing 4-aminophenylacetic acid compounds
|
|
AR036797A1
(es)
|
2001-10-15 |
2004-10-06 |
Ferring Bv |
Un metodo para preparar una composicion farmaceutica que comprende acido 5-aminosalicilico para utilizar en el tratamiento de colitis ulcerosa y enfermedades de crohn
|
|
JP2007523664A
(ja)
*
|
2003-04-23 |
2007-08-23 |
フェリング ベスローテン フェンノートシャップ |
医薬組成物用サシェ
|
|
CN1972698B
(zh)
|
2003-09-01 |
2010-06-02 |
有限会社爱泽世 |
β-羟基短-中链脂肪酸聚合物
|
|
US7825106B2
(en)
|
2003-09-03 |
2010-11-02 |
Agi Therapeutics Ltd. |
Modified release formulations and methods of treating inflammatory bowel disease
|
|
US7737133B2
(en)
*
|
2003-09-03 |
2010-06-15 |
Agi Therapeutics Ltd. |
Formulations and methods of treating inflammatory bowel disease
|
|
US7417037B2
(en)
*
|
2004-01-20 |
2008-08-26 |
The Board Of Regents Of The University Of Oklahoma |
Compositions and methods of treatment for inflammatory diseases
|
|
ZA200607435B
(en)
|
2004-02-06 |
2009-05-27 |
Pharmatel Red Pty Ltd As The T |
Use of aminosalicylates in diarrhoea-predominant irritable bowel syndrome
|
|
JP5009152B2
(ja)
*
|
2004-05-28 |
2012-08-22 |
サリックス ファーマシューティカルズ， インコーポレイテッド |
放射線誘発性腸炎の予防、処置、および回復
|
|
CA2572223C
(en)
|
2004-06-25 |
2014-08-12 |
The Johns Hopkins University |
Angiogenesis inhibitors
|
|
PL1773767T3
(pl)
|
2004-07-07 |
2016-07-29 |
Biocon Ltd |
Synteza azowo związanych związków immunoregulacyjnych
|
|
DE602005013098D1
(de)
*
|
2004-09-01 |
2009-04-16 |
Procter & Gamble |
Zusammensetzungen mit 5-amino-2-hydroxybenzoesäure und einem reduzierendem zucker
|
|
US9149439B2
(en)
*
|
2005-03-21 |
2015-10-06 |
Sandoz Ag |
Multi-particulate, modified-release composition
|
|
US20090017110A1
(en)
*
|
2005-05-31 |
2009-01-15 |
Capricorn Pharma Inc. |
Modified release formulations of anti-irritability drugs
|
|
US8921344B2
(en)
*
|
2006-11-03 |
2014-12-30 |
Salix Pharmaceuticals, Inc. |
Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives
|
|
US7452872B2
(en)
|
2005-08-24 |
2008-11-18 |
Salix Pharmaceuticals, Inc. |
Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives
|
|
CA2816276A1
(en)
*
|
2005-08-24 |
2007-03-01 |
Salix Pharmaceuticals, Inc. |
Balsalazide formulations and manufacture and use thereof
|
|
US7964215B1
(en)
|
2006-01-24 |
2011-06-21 |
Emet Pharmaceuticals, LLC |
Delayed release dosage form
|
|
GB0607534D0
(en)
*
|
2006-04-13 |
2006-05-24 |
Univ London Pharmacy |
Colonic drug delivery formulation
|
|
EP2024323B1
(en)
*
|
2006-06-06 |
2013-03-27 |
Gicare Pharma Inc. |
Salts of trimebutine and n-desmethyl trimebutine
|
|
CA2662430A1
(en)
*
|
2006-09-13 |
2008-03-20 |
The Procter & Gamble Company |
Methods of treatment for ulcerative colitis using aminosalicylate
|
|
MX2009002785A
(es)
*
|
2006-09-13 |
2009-03-30 |
Procter & Gamble |
Metodos para el tratamiento de la colitis ulcerosa.
|
|
WO2008085484A2
(en)
*
|
2006-12-28 |
2008-07-17 |
Jacobus Pharmaceutical Company, Inc. |
Treatment of inflammatory bowel disease with enteric coated formulations comprising 5-aminosalicylic acid or 4-aminosalicylic acid
|
|
US20090028944A1
(en)
*
|
2007-07-16 |
2009-01-29 |
Balaji Sathurappan |
Pharmaceutical compositions comprising mesalamine
|
|
US20090036414A1
(en)
*
|
2007-08-02 |
2009-02-05 |
Mutual Pharmaceutical Company, Inc. |
Mesalamine Formulations
|
|
US20090162434A1
(en)
*
|
2007-12-21 |
2009-06-25 |
Disphar International Bv |
Mesalazine tablet
|
|
US20090169622A1
(en)
*
|
2007-12-27 |
2009-07-02 |
Roxane Laboratories, Inc. |
Delayed-release oral pharmaceutical composition for treatment of colonic disorders
|
|
MX2011003595A
(es)
*
|
2008-10-03 |
2011-07-28 |
Falk Pharma Gmbh |
Composiciones y metodos para el tratamiento de enfermedades intestinales con mesalamina granulada.
|
|
US8729097B2
(en)
|
2008-10-06 |
2014-05-20 |
The Johns Hopkins University |
Quinoline compounds as inhibitors of angiogenesis, human methionine aminopeptidase, and SIRT1, and methods of treating disorders
|
|
EP2488163A1
(en)
|
2009-10-16 |
2012-08-22 |
Ranbaxy Laboratories Limited |
A delayed release pharmaceutical composition of mesalamine
|
|
US10154964B2
(en)
|
2011-09-07 |
2018-12-18 |
Cosmo Technologies Limited |
Controlled release and taste masking oral pharmaceutical composition
|
|
JP6203816B2
(ja)
|
2012-03-29 |
2017-09-27 |
セラバイオーム，エルエルシー |
回腸及び虫垂に対して活性の胃腸部位特異的経口ワクチン接種製剤
|
|
US20140066837A1
(en)
|
2012-07-26 |
2014-03-06 |
Ronald L. Moy |
Skin care compositions and methods
|
|
US20140141075A1
(en)
|
2012-11-21 |
2014-05-22 |
Warner Chilcott Company, Llc |
5-aminosalicylic acid capsule formulation
|
|
WO2014152338A1
(en)
|
2013-03-14 |
2014-09-25 |
Kabadi Mohan |
Targeted gastrointestinal tract delivery of probiotic organisms and/or therapeutic agents
|
|
EP2953619A1
(en)
|
2013-03-15 |
2015-12-16 |
Warner Chilcott Company, LLC |
Mesalamine pharmaceutical composition with multiple dosage elements for reduced delivery variability
|
|
US9539265B2
(en)
|
2013-03-15 |
2017-01-10 |
Aihol Corporation |
Pharmaceutical formulation containing glycosaminoglycan
|
|
KR102341899B1
(ko)
|
2013-04-07 |
2021-12-21 |
더 브로드 인스티튜트, 인코퍼레이티드 |
개인맞춤화 신생물 백신을 위한 조성물 및 방법
|
|
US10801070B2
(en)
|
2013-11-25 |
2020-10-13 |
The Broad Institute, Inc. |
Compositions and methods for diagnosing, evaluating and treating cancer
|
|
WO2015085147A1
(en)
|
2013-12-05 |
2015-06-11 |
The Broad Institute Inc. |
Polymorphic gene typing and somatic change detection using sequencing data
|
|
KR20160101073A
(ko)
|
2013-12-20 |
2016-08-24 |
더 브로드 인스티튜트, 인코퍼레이티드 |
신생항원 백신과의 병용 요법
|
|
CA2936748C
(en)
|
2014-10-31 |
2017-08-08 |
Purdue Pharma |
Methods and compositions particularly for treatment of attention deficit disorder
|
|
US10975442B2
(en)
|
2014-12-19 |
2021-04-13 |
Massachusetts Institute Of Technology |
Molecular biomarkers for cancer immunotherapy
|
|
WO2016100977A1
(en)
|
2014-12-19 |
2016-06-23 |
The Broad Institute Inc. |
Methods for profiling the t-cel- receptor repertoire
|
|
WO2016187508A2
(en)
|
2015-05-20 |
2016-11-24 |
The Broad Institute Inc. |
Shared neoantigens
|
|
USD809116S1
(en)
|
2015-11-02 |
2018-01-30 |
Pura Scents |
Dispenser
|
|
CA3102210C
(en)
|
2015-11-02 |
2022-06-14 |
Pura Scents, Inc. |
Scent dispensation
|
|
USD816506S1
(en)
|
2015-11-02 |
2018-05-01 |
Pura Scents, Inc. |
Vial for a scent dispenser
|
|
EP3446119A1
(en)
|
2016-04-18 |
2019-02-27 |
The Broad Institute Inc. |
Improved hla epitope prediction
|
|
EP3257501A1
(en)
|
2016-06-14 |
2017-12-20 |
Tillotts Pharma AG |
Multiple unit dosage form comprising a core with individual core units covered by a mucoadhesive material, and an enteric core coating
|
|
US11549149B2
(en)
|
2017-01-24 |
2023-01-10 |
The Broad Institute, Inc. |
Compositions and methods for detecting a mutant variant of a polynucleotide
|
|
US10098898B1
(en)
|
2017-12-04 |
2018-10-16 |
Handa Pharmaceuticals, Llc |
Release stable mesalamine dosage forms
|
|
US20210382068A1
(en)
|
2018-10-02 |
2021-12-09 |
Dana-Farber Cancer Institute, Inc. |
Hla single allele lines
|
|
US10722473B2
(en)
|
2018-11-19 |
2020-07-28 |
Purdue Pharma L.P. |
Methods and compositions particularly for treatment of attention deficit disorder
|
|
WO2020131586A2
(en)
|
2018-12-17 |
2020-06-25 |
The Broad Institute, Inc. |
Methods for identifying neoantigens
|
|
CN116249774A
(zh)
|
2020-05-26 |
2023-06-09 |
迪奥尼斯治疗公司 |
核酸人工微型蛋白质组文库
|
|
WO2023076733A1
(en)
|
2021-11-01 |
2023-05-04 |
Dana-Farber Cancer Institute, Inc. |
Biologically selected nucleic acid artificial mini-proteome libraries
|